The cancer of the ovaries is one of the most common types of cancer in women. It affects women after menopause.
Symptoms of ovarian cancer include feeling constantly bloated, discomfort in stomach, feeling full quickly when eating, and frequent urination.
The study authors used an experimental drug called birinapant, in addition to the usual carboplatin, in mice with ovarian cancer tumours, and discovered it could boost survival.
The researchers enlisted birinapant – it deregrades proteins called cIAPs, which prevent cell death after chemotherapy – to make the chemotherapy drug more effective against ovarian cancer tumours.